PharmaCare Analysis

3097 Words7 Pages

Three ethical issues relating to marketing and advertising are Truth in Adverting and Marketing, Advertising and Marketing Harmful Products and Advertising and Marketing Tactics. The FDA (Food and Drug Administration) has requirements for truth in advertising and the FTC
(Federal Trade Commission) enforces the provisions of this act. Marketing and advertising is an effective way to introduce products or services and to increase sales. However it could also be a tool company’s use unethically. Any information that is likely to mislead consumers into purchasing or using products and services that is deceptive or unfair comes under the radar of the FTC. An example of this, weight loss products, actions have been taken against hundreds of advertiser who ensured weight loss if you used their products and followed their plan. The consumer must be educated of the actual risks as well as benefits. Marketing diet products or services must be factual and backed up with proof (Scientific Evidence). Violators could be penalize by a cease and desist order which makes the company stop running the illegal ad or deceptive practice. The company would in the future report to the FTC staff regarding all future ads and pay a fine of $16,000.00 a day for all future violations. There are other penalties like civil suits and corrective advertising, costing the violator thousands or millions of dollars. Corrective advertising is a method used to make the violator take out a new ad and correct any false or misleading information that was conveyed in the original ad. In addition, notification to all affected must be addressed such as consumers or purchasers. Manufacturers, distributors, service providers should be honest in all respects as it relates to it...

... middle of paper ...

...supported by a strong case management and anonymous reporting system to allow for a clear understanding of activities from the ground up and vice versa.

Works Cited

http://www.ftc.gov/ftc/history/ftchistory.shtm

http://www.iccwbo.org/advocacy-codes-and-rules/areas-of-work/intellectual-property/intellectual-property-basics/ http://www.asiabusinesscouncil.org/docs/IntellectualPropertyRights.pdf http://www.pharmacist.com/senate-considers-drug-compounding-bill http://www.help.senate.gov/newsroom/press/release/?id=549b94cd-bca0-470d-aa39-3cfe1cea055f http://www.law.cornell.edu/wex/securities_exchange_act_of_1934 http://www.pewhealth.org/other-resource/improving-the-safety-and-quality-of-our-drug-supply-85899520 http://www.jdsupra.com/legalnews/compound-pharmacy-regulatory-update-sen-19679/
http://www.chemicalspolicy.org/downloads/UMassLowellConsumerProductBrief.pdf

Open Document